Patient-Reported Outcome Measurement and Reporting for Patients with Soft Tissue Tumors: A Scoping Literature Review.

While the lack of QoL data in a negative clinical trial can be considered almost insignificant, a positive trial represents the first step for a drug to obtain regulatory approval and be included in clinical guidelines and routine clinical practice.

also in 172 other papers